de
  • Deutsch - de
  • English - en
  • Über uns
      Über uns
        Maßnahmen
          Mitglieder
            Cluster Management
              PhD und Postdoc-Vertreter
                Wissenschaftlicher Beirat
                  Internationale Kooperationspartner
                    Timeline
                      Pressekit
                        Kontakt
                      • Aktuelles
                          News
                            Veranstaltungen
                              Presseecho
                                Stellenausschreibungen
                              • Forschung
                                  Publikationen
                                    Unser Forschungsschwerpunkt
                                      Technology Hubs
                                        "Research Spotlight"
                                          Datenmanagement & -austausch
                                            Sustainability Initiative
                                              Verhaltenskodex
                                            • Wissenschaft & Gesellschaft
                                                Für Schulen und Schüler
                                                  Öffentliche Veranstaltungen
                                                    Podcasts
                                                      Videos
                                                    • Support für Diversity & Equity
                                                        Newcomer Center
                                                          Gender Equality Program
                                                            Early Career Investigator Programm
                                                          1. Home
                                                          2. Aktuelles
                                                          3. News
                                                          4. MIF-2: An atypical chemokine connecting vascular inflammation to metabolic dysfunction in atherosclerosis
                                                          News | 25.03.2025 | Research Spotlight

                                                          MIF-2: An atypical chemokine connecting vascular inflammation to metabolic dysfunction in atherosclerosis

                                                          Atherosclerotic cardiovascular diseases, including myocardial infarction and ischemic stroke, are the leading cause of mortality worldwide. A team of researchers shows that the protein MIF-2/D-DT acts as an atypical chemokine and a non-cognate ligand of CXCR4, which helps promote the development of atherosclerosis and inflammation in blood vessels. The study improves our understanding of how inflammation in blood vessels is connected to liver problems in atherosclerotic diseases and points out potential treatment pathways.
                                                           Research Spotlight: photo of researcher with citation on impact of research

                                                          This is a summary of El Bounkari, O., Zan, C., Yang, B. et al. (2025). An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis, published in Nature Communications: https://doi.org/10.1038/s41467-025-57540-z


                                                          The challenge

                                                          Atherosclerosis is the underlying condition responsible for both myocardial infarction and ischemic stroke; it is a chronic inflammatory disease of the arterial walls triggered by lipids and driven by immune and inflammatory pathways. For this study, we looked at the role of macrophage migration-inhibitory factor (MIF) proteins in atherosclerosis; MIF is a multifunctional inflammatory mediator implicated in various inflammatory diseases. Elevated plasma MIF levels are associated with coronary artery disease (CAD). Previous research, including our own, has shown increased MIF expression in atherosclerotic plaques and has demonstrated that MIF promotes the recruitment of atherogenic leukocytes through non-cognate interactions with chemokine receptors such as CXCR2 and CXCR4. Consequently, MIF is classified as an atypical chemokine, which is an emerging family of proteins that bind to classical chemokine receptors but lack typical chemokine structural features. While previous research has provided us with a reasonable understanding of the contribution of MIF, i.e. primarily driving vascular inflammation in atherosclerosis, the role of the MIF paralog MIF-2 (also termed D-dopachrome tautomerase, D-DT) in atherosclerosis had been unknown.


                                                          Our approach

                                                          We employed mouse models to study the role of MIF-2 in both early and advanced atherosclerosis. Specifically, we used Apolipoprotein E-deficient (Apoe–/–) mice, either with a deficiency in Mif-2 or under pharmacological Mif-2 blockade, to examine the role of MIF-2 in the development of atherosclerosis. Additionally, we conducted mechanistic experiments that included transcriptomics, lipidomics, hepatocyte cultures, SREBP and target gene analysis, receptor blocking, proximity ligation assay (PLA), and FLIM/FRET techniques.


                                                          Our findings

                                                          We discovered that Mif-2–/–Apoe–/– mice on a high-fat diet had fewer atherosclerotic lesions, reduced vascular inflammation, and lower levels of circulating inflammatory cytokines in both early and advanced stages of atherogenesis compared to Apoe–/– mice. We identified MIF-2 as a pro-atherogenic atypical chemokine and CXCR4 as its receptor. Unlike MIF, MIF-2 is also associated with lipid accumulation in the liver, and elevated levels of MIF-2 correlate with unstable carotid artery plaques and symptomatic coronary plaques. This suggests that MIF-2 plays a role in advanced atherosclerotic diseases, affecting both lipid/hepatic processes and vascular health.


                                                          The implications

                                                          These findings identify the protein MIF-2 as an atypical chemokine that links vascular inflammation to metabolic dysfunction in atherosclerosis. Our overall data suggest that MIF-2 could be a promising therapeutic target for atherosclerosis, vascular inflammation, and related metabolic conditions. Targeting MIF-2 may be most effective when combined with targeting MIF, as both MIF and MIF-2 are significant pro-atherogenic mediators that worsen vascular inflammation and lesion formation.


                                                          Creating SyNergies

                                                          The study was led by Jürgen Bernhagen, and Omar El Bounkari, a senior staff scientist in the BernhagenLab, and included SyNergy member Christian Weber. The project exemplies SyNergy efforts to comprehensively characterize interactions between cardio- and cerebro-vascular pathologies, inflammation, and metabolic diseases, including dyslipidemia, and will flank SyNergy’s aim to identify targets for translational approaches.  

                                                          Teilnehmende Universitäten
                                                           LMU logo in white
                                                           TUM logo in white
                                                          Partnerinstitute
                                                           Logo DZNE in white
                                                          Helmholtz Munich logo in white 
                                                           Logo Max Planck Gesellschaft 

                                                          SyNergy wird von der Deutschen Forschungsgemeinschaft im Rahmen der deutschen Exzellenzstrategie gefördert (EXC 2145 SyNergy - ID 390857198). Die Exzellenzstrategie fördert herausragende Forschung an deutschen Universitäten. 

                                                          Kontakt

                                                          Munich Cluster for Systems Neurology (SyNergy)

                                                          Feodor-Lynen-Str. 17
                                                          81377 Munich
                                                          +49 (0)89 4400-46497
                                                          yüubgybcјuipxј_vfulyz mi
                                                          Redakteurs Login
                                                          Impressum | Datenschutz
                                                          de
                                                          • Deutsch - de
                                                          • English - en

                                                          SyNergy - Mu...

                                                          • Über uns
                                                            • Über uns
                                                            • Maßnahmen
                                                            • Mitglieder
                                                            • Cluster Management
                                                            • PhD und Postdoc-Vertreter
                                                            • Wissenschaftlicher Beirat
                                                            • Internationale Kooperationspartner
                                                            • Timeline
                                                            • Pressekit
                                                            • Kontakt
                                                          • Aktuelles
                                                            • News
                                                            • Veranstaltungen
                                                            • Presseecho
                                                            • Stellenausschreibungen
                                                          • Forschung
                                                            • Publikationen
                                                            • Unser Forschungsschwerpunkt
                                                            • Technology Hubs
                                                            • "Research Spotlight"
                                                            • Datenmanagement & -austausch
                                                            • Sustainability Initiative
                                                            • Verhaltenskodex
                                                          • Wissenschaft & Gesellschaft
                                                            • Für Schulen und Schüler
                                                            • Öffentliche Veranstaltungen
                                                            • Podcasts
                                                            • Videos
                                                          • Support für Diversity & Equity
                                                            • Newcomer Center
                                                            • Gender Equality Program
                                                            • Early Career Investigator Programm